CLXR-005

N/A

Report date: 2023/09/01 09:11:02
NME

Base Information

Drug NameCLXR-005
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceSignal transducer and activator of transcription 6 inhibitors
TargetsSignal transducer and activator of transcription 6
Therapy Area/IndicationsColorectal NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelixir
China Registration ClassN/A

Develop Information

Active CompaniesCelixir
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A